National Institute of Virology Current Affairs, GK & News

COVAXIN neutralises double Mutant Strain

The Indian Council of Medical Research recently announced that COVAXIN neutralises the Double Mutant Strain of COVID-19. Key Highlights The National Institute of Virology recently demonstrated the neutralisation potential of COVAXIN against the Brazil variant and UK variant. The B.1.617 is a recently spreading double mutant variant of COVID-19. It carries the mutations of E484Q ..

Month: 

Category: 

Topics: 

What is Double Mutant Corona Virus Variant?

The National Institute of Virology recently shared a data showing the break up of 361 genome sequenced samples that were collected between January and March 2021. Key Findings The study detected the presence of double mutation in almost 61% of the samples collected in Maharashtra. The double mutant has been classified as B.1.617 recently. What ..

Month: 

Category: 

Topics: 

COVAXIN of Bharat Biotech enters Phase III trials: Largest COVID-19 clinical trial of India

On November 16, 2020 the Bharat Biotech announced the commencement of Phase III trials of COVAXIN vaccines in India. The trials will involve 26,000 volunteers. It is to be held in partnership with the Indian Council of Medical Research. The trials are the largest clinical trials that is conducted for COVID-19 vaccine in the country. ..

Month: 

Category: 

Topics: 

Indigenously Developed ‘COVAXIN’ gets DCGI approval for Human Clinical Trials

The Drug Controller General of India (DCGI) has given approval for Phase I and Phase II human clinical trials for COVID-19 vaccine ‘COVAXIN’. In association with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV), COVAXIN is developed by Hyderabad based vaccine & bio-therapeutics manufacturer-Bharat Biotech.  At NIV Pune, the ..

Month: 

Category: 

Topics: 

Sero-Survey begins in New Delhi to determine the Spread of COVID-19

As a part of one of the five aspects of the revised COVID-19 response plan of New Delhi, the Delhi Government jointly with National Centre for Disease Control will conduct the Sero Survey across the National Capital from 27th June 2020. Amidst a rising number of COVID-19 cases over the last one month, the Survey ..

Month: 

Topics: